OverviewAccording to publications of analysts, it is expected that with the help of IT tools and by outsourcing R&D activities, the costs for developing a new drug can be reduced to approximately 50% to 66% of today's costs. Projections call for the total life science informatics market to grow from € 2.85 billion (2000) to € 15.7 billion by 2005, representing an annual compound growth rate of over 40%.
The total software market for rational drug design covers approximately € 200-230 million. Analysts expect this market to grow by 50% per year in the next future. Even based on a conservative estimated growth rate of 20% in the following years a market volume of € 450-560 million will result in 2005. Inte:Ligand's products and services are positioned in this area of necessary developments for the pharmaceutical industry.